Hoth Therapeutics, Inc.

HOTH · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$4,106-$2,199-$3,476-$2,383
Dep. & Amort.$0-$4$4$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$220$0
Change in WC$454-$228-$387$354
Other Non-Cash$1,159$59$851$1
Operating Cash Flow-$2,493-$2,373-$2,788-$2,028
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$300$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$300$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$2,003$66$7,067$1,061
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$376$0$0$0
Financing Cash Flow$1,627$66$7,067$1,061
Forex Effect-$1$3-$0-$17
Net Chg. in Cash-$1,166-$2,303$4,278-$984
Supplemental Information
Beg. Cash$9,014$11,317$7,039$8,023
End Cash$7,848$9,014$11,317$7,039
Free Cash Flow-$2,493-$2,373-$2,788-$2,028
Hoth Therapeutics, Inc. (HOTH) Financial Statements & Key Stats | AlphaPilot